[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591664":3},{"organization":4,"armGroups":7,"interventions":42,"overallOfficials":48,"centralContacts":54,"locations":59,"responsibleParty":82,"collaborators":85,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":10,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":97,"minAge":98,"maxAge":10,"enrollmentInfo":99,"targetDuration":10,"studyType":102,"phases":10,"briefSummary":103,"conditions":104,"keywords":10,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14,18,22,26,30,34,38],{"label":9,"type":10,"description":11,"interventionNames":12},"Chronic obstructive pulmonary disease (COPD)",null,"Chronic obstructive pulmonary disease patients will be further classified as mild, moderate, severe, and very severe according to GOLD classification.",[13],"Diagnostic Test: Lung Ultrasound",{"label":15,"type":10,"description":16,"interventionNames":17},"Pneumothorax","Patients with Pneumothorax",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Community-acquired pneumonia (CAP)","Community-acquired pneumonia will be classified using the CURB-65 score into mild, moderate, and severe.",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Interstitial lung diseases (ILDs)","Interstitial lung diseases will be further classified using FVC% classes, categorized as mild, moderate, and severe.",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Bronchiectasis","patients with non-cystic fibrosis bronchiectasis",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Pleural Effusion","Patients with pleural effusion",[13],{"label":35,"type":10,"description":36,"interventionNames":37},"Pulmonary Oedema","Patient with any degree of Pulmonary oedema",[13],{"label":39,"type":10,"description":40,"interventionNames":41},"Control","Healthy control subjects for comparison",[13],[43],{"type":44,"name":45,"description":46,"armGroupLabels":47,"otherNames":10},"DIAGNOSTIC_TEST","Lung Ultrasound","All enrolled patient will be subjected to Lung Ultrasound examination LUS",[27,9,19,39,23,31,15,35],[49,52],{"name":50,"affiliation":5,"role":51},"Ahmad M. Shaddad, MD","PRINCIPAL_INVESTIGATOR",{"name":53,"affiliation":5,"role":51},"Aliae A. Hussien, MD",[55],{"name":50,"role":56,"phone":57,"phoneExt":10,"email":58},"CONTACT","+201111171930","shaddad_ahmad@yahoo.com",[60],{"facility":61,"status":62,"city":63,"state":10,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":73},"Assiut University- Faculty of Medicine","RECRUITING","Asyut","71515","Egypt","EG",{"type":68,"coordinates":69},"Point",[70,71],31.18368,27.18096,{"lat":71,"lon":70},[74,77,78,80],{"name":50,"role":56,"phone":75,"phoneExt":10,"email":76},"+201111171939","Shaddad_ahmad@aun.edu.eg",{"name":50,"role":51,"phone":10,"phoneExt":10,"email":10},{"name":79,"role":51,"phone":10,"phoneExt":10,"email":10},"Aliae A Hussein, MD",{"name":81,"role":51,"phone":10,"phoneExt":10,"email":10},"Maiada K Haahem, MD",{"type":51,"investigatorFullName":83,"investigatorTitle":84,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Ahmad Shaddad","Associate professor of pulmonary medicine - faculty of medicine - Assuit University",[86],{"name":87,"class":88},"Aliae AR Mohamed Hussein [ahussein","UNKNOWN","100591664","validation-and-clinical-utility-of-the-lung-sliding-index-lsi-for-differentiating-pulmonary-diseases-100591664",false,"NCT06983366","Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases","Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases: A Prospective Case-Control Study","Inclusion Criteria:\n\n* Age 18 years and older.\n* Diagnosed with one of the specified pulmonary diseases, or a healthy control\n* Able to provide written informed consent\n\nExclusion Criteria:\n\n* Inability to tolerate or undergo a lung ultrasound\n* Extensive chest wall pathology precluding assessment\n* Unscorable \\>2 zones per protocol\n* Withdrawal of consent\n* Mechanically-ventilated patients",true,"ALL","18 Years",{"count":100,"type":101},700,"ESTIMATED","OBSERVATIONAL","This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.",[105,106,27,15,107,108,35],"COPD","ILD","Pneumonia","Pleural Effusion Disorder","2026-04-26",{"date":111,"type":112},"2026-04-30","ACTUAL",{"date":114,"type":112},"2025-05-30",{"date":116,"type":101},"2026-08-01",{"name":5,"class":6},1]